Americans hungry for weight-loss drugs grapple with supply and insurance hurdles
Item 1 of 2 An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/File PhotoAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed…